Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 22, 2019 11:05 ET | Source: PetCure Oncology

Radiation Therapy for Pets: New Outcomes Data Presented by PetCure Oncology at Veterinary Cancer Society Annual Conference

Houston, TX, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Just a few weeks after celebrating the treatment of its 3,000th pet, national pet cancer care provider PetCure Oncology presented data suggesting that...
September 26, 2019 11:45 ET | Source: PetCure Oncology

PetCure Oncology Continues to Drive Radiation Therapy for Pets with 3,000th Treatment

Deerfield, IL, Sept. 26, 2019 (GLOBE NEWSWIRE) -- National pet cancer care provider PetCure Oncology treated its 3,000th pet with advanced radiation therapy on Wednesday, reaching a historic...
July 17, 2019 09:00 ET | Source: PetCure Oncology

PetCure Oncology Announces Capital Raise with Plans for Public Offering, Expansion of Pet Cancer Network

Deerfield, IL, July 17, 2019 (GLOBE NEWSWIRE) -- PetCure Oncology, LLC, a company providing veterinary cancer treatment utilizing non-surgical stereotactic radiosurgery (SRS) and stereotactic...
July 08, 2019 13:00 ET | Source: Boustead Securities

PetCure Oncology Engages Boustead Securities, LLC for Regulation D 506(C) Offering and Planned National Exchange Listing

Irvine, CA, July 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Boustead Securities, LLC announced today that it has entered into an engagement agreement with PetCure Oncology, LLC, a company...
December 07, 2017 10:00 ET | Source: PetCure Oncology

PetCure Oncology and Nanovi Announce PetXmark™ Partnership to Introduce Fiducial Guided Stereotactic Radiotherapy for Pet Patients with Cancers

Chicago, IL and Copenhagen, Denmark, Dec. 07, 2017 (GLOBE NEWSWIRE) -- PetCure Oncology Inc. (PetCure) and Nanovi A/S (Nanovi) announced an exclusive agreement to use PetXmark™ in the development...